chr1-204137188-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000367202.9(ETNK2):āc.930C>Gā(p.His310Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000555 in 1,613,968 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000367202.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETNK2 | NM_018208.4 | c.930C>G | p.His310Gln | missense_variant | 6/8 | ENST00000367202.9 | NP_060678.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ETNK2 | ENST00000367202.9 | c.930C>G | p.His310Gln | missense_variant | 6/8 | 1 | NM_018208.4 | ENSP00000356170 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000590 AC: 148AN: 251052Hom.: 1 AF XY: 0.000641 AC XY: 87AN XY: 135686
GnomAD4 exome AF: 0.000573 AC: 838AN: 1461638Hom.: 2 Cov.: 31 AF XY: 0.000619 AC XY: 450AN XY: 727114
GnomAD4 genome AF: 0.000381 AC: 58AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000349 AC XY: 26AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.930C>G (p.H310Q) alteration is located in exon 6 (coding exon 6) of the ETNK2 gene. This alteration results from a C to G substitution at nucleotide position 930, causing the histidine (H) at amino acid position 310 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at